Pivot Bio IPO
Pivot Bio is an agricultural technology company that develops nitrogen-producing microbes as an alternative to synthetic fertilizers. The company's microbial technology helps farmers reduce fertilizer costs while maintaining crop yields and reducing environmental impact. Investors see IPO potential in Pivot Bio due to growing demand for sustainable agriculture solutions and the company's innovative approach to crop nutrition.
What We Know
Pivot Bio has not announced any IPO plans. The company has raised significant venture funding, including a $430 million Series D round in 2021 that valued the company at over $2 billion, achieving unicorn status in the agricultural technology sector. Despite strong funding milestones and growing adoption of its microbial nitrogen technology among farmers, Pivot Bio has not indicated any timeline for going public. The agricultural technology market has seen varied IPO performance, and the company may be focusing on scaling its biological manufacturing capabilities and expanding market penetration before considering public markets. The sustainable agriculture sector continues to attract significant investor interest driven by environmental and economic benefits.
Frequently Asked Questions
Has Pivot Bio had an IPO?
No, Pivot Bio has not had an IPO. The company is privately held despite achieving unicorn valuation status.
When is the Pivot Bio IPO date?
Pivot Bio has not announced an IPO date or timeline. No confirmed details are available about when the company might consider going public. Sign up for alerts to stay informed.
How can I buy Pivot Bio stock?
Pivot Bio stock is not available for public purchase. As a private company, shares are only accessible to private investors and employees. Sign up for alerts to stay informed.
Stay Updated on the Pivot Bio IPO
Get real-time alerts when Pivot Bio files for an IPO, prices shares, or begins trading.
Get IPO Alerts